|
Delayed
Canadian Securities Exchange
13:44:48 2026-10-15 EDT
|
5-day change | 1st Jan Change | ||
| 0.0100 CAD | 0.00% |
|
0.00% | -20.00% |
| Market Cap | 5.21M 3.7M 3.29M 3.05M 2.78M 350M 5.29M 36.61M 14.4M 183M 13.87M 13.58M 586M | P/E 2024 |
-4.18x | P/E 2025 | -22.7x |
|---|---|---|---|---|---|
| Enterprise Value | 22.27M 15.8M 14.09M 13.05M 11.87M 1.5B 22.63M 157M 61.55M 783M 59.3M 58.06M 2.5B | EV / Sales 2024 |
1.1x | EV / Sales 2025 | 1.26x |
| Free-Float |
86.8% | Yield 2024 * |
-
| Yield 2025 | - |
Canadian Securities ExchangeCAD
| Markets | Quality | ||
|---|---|---|---|
Canadian Securities Exchange
| QF | Delayed | |
OTC Markets
| TGIFF | Delayed |
| 3 months | +100.00% | ||
| Current year | -20.00% |
| 1 week | 0 |  | 0.01 |
| 1 month | 0 | | 0.02 |
| Current year | 0 | | 0.02 |
| 1 year | 0 | | 0.02 |
| 3 years | 0 | | 0.02 |
| 5 years | 0 | | 0.08 |
| 10 years | 0 | | 1.48 |
| Manager | Title | Age | Since |
|---|---|---|---|
Brian Farrell
CEO | Chief Executive Officer | - | 2025-01-31 |
Jeremy Fong
DFI | Director of Finance/CFO | 34 | 2025-01-31 |
Ester Vigil
PSD | President | - | 2023-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Farrell
CHM | Chairman | - | 2025-01-31 |
Paul Rosen
CHM | Chairman | 62 | 2021-01-28 |
Curtis Floyd
BRD | Director/Board Member | - | 2023-06-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 12/1/25 | Option | Company Secretary | 100,000 | 0.0204% | ||
| 12/1/25 | Option | Investor Relations Manager | 200,000 | 0.0408% | ||
| 9/22/25 | Buy | Chief Executive Officer | 2,000,000 | 0.4078% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | 0.00% | -33.33% | 3.68M | |
| -0.63% | +5.52% | +54.26% | +111.22% | 1,120B | |
| -0.67% | -3.95% | +30.76% | +66.29% | 616B | |
| -0.43% | +1.01% | +22.36% | +95.13% | 504B | |
| +0.24% | +5.58% | +35.22% | +59.40% | 367B | |
| -0.92% | -0.60% | +67.49% | +43.96% | 360B | |
| -0.40% | +3.53% | +19.26% | +46.55% | 288B | |
| -0.37% | +3.11% | -1.31% | +18.23% | 258B | |
| -0.97% | +2.40% | +40.97% | +52.38% | 234B | |
| -0.94% | +2.70% | +25.49% | +96.95% | 194B | |
| Average | -0.53% | +2.98% | +29.45% | +55.68% | 394.09B | |
| Weighted average by Cap. | -0.59% | +3.52% | +37.55% | +76.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 19.35M 13.74M 12.24M 11.34M 10.31M 1.3B 19.67M 136M 53.49M 681M 51.53M 50.46M 2.18B | 17.45M 12.38M 11.04M 10.23M 9.3M 1.17B 17.73M 123M 48.23M 614M 46.46M 45.49M 1.96B |
| Net income | -1.14M -811K -723K -669K -609K -76.85M -1.16M -8.03M -3.16M -40.17M -3.04M -2.98M -128M | -217K -154K -137K -127K -116K -14.61M -221K -1.53M -600K -7.63M -578K -566K -24.4M |
| Net Debt | 16.33M 11.59M 10.33M 9.57M 8.7M 1.1B 16.6M 115M 45.13M 574M 43.48M 42.57M 1.84B | 17.06M 12.11M 10.79M 10M 9.09M 1.15B 17.34M 120M 47.15M 600M 45.43M 44.48M 1.92B |
Employees
85
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-15 | $0.0100 | 0.00% | 10,500 |
| 26-10-14 | $0.0100 | +100.00% | 9,000 |
| 26-10-13 | $0.005000 | -50.00% | 350,000 |
- Stock Market
- Stocks
- QF Stock
Select your edition
All financial news and data tailored to specific country editions
